Navigation Links
Cancer Drug Doesn't Speed Up Tumor Growth, Researchers Say
Date:2/7/2013

THURSDAY, Feb. 7 (HealthDay News) -- The anticancer drug Sutent (sunitinib) does not cause tumors to grow faster after treatment ends, according to a new study.

Previous research in animals suggested that tumor growth may accelerate after patients stopped taking Sutent. The new findings, from a study of kidney cancer patients, indicate that the drug does not pose lingering risks for humans.

The researchers analyzed data from a phase 3 clinical trial that led to Sutent's approval. They concluded that regardless of how long patients took the drug, it did not cause harm, did not speed up tumor growth and survival was not shortened after treatment ended, according to the findings published online Feb. 7 in the journal Cell Reports.

During treatment, Sutent slowed tumor growth and extended patients' lives, the investigators pointed out in a journal news release.

Sutent, which is approved for the treatment of several different cancers, targets proteins on the blood vessels that feed tumors.

"Last year, I was approached by two patients who had grave concerns about taking sunitinib due to an article [about research] conducted in animals. I realized that if clinical data exist that refute basic science, they must be published," study senior author Dr. Tito Fojo, of the U.S. National Cancer Institute, said in the news release.

These new findings should reassure patients, the study authors suggested.

"We hope [these findings] can be generalized to similar drugs but recognize that further studies will be needed," study first author Dr. Krastan Blagoev, of the U.S. National Science Foundation, said in the news release. "Nevertheless, other drugs also approved worldwide for a variety of cancers -- including sorafenib, pazopanib, and axitinib -- are similar to sunitinib, and this will give some reassurances that one need not expect things to get worse after such drugs are discontinued."

More info
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. New Stool Test Might Aid in Early Detection of Colon Cancer
3. Study reveals how cancer drug causes diabetic-like state
4. How a cancer drug leads to diabetes
5. You Survived Cancer: Now Pay Attention to Your Overall Health
6. New drug prevents spread of human prostate cancer cells
7. Eliminating the good cholesterol receptor may fight breast cancer
8. Taller, Heavier Women May Face Higher Ovarian Cancer Risk
9. Experimental Chemo Combo for Colon Cancer Disappoints
10. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
11. Targeted therapeutics for colon cancer to be presented at AACR meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer Drug Doesn't Speed Up Tumor Growth, Researchers Say
(Date:6/19/2013)... June 19, 2013 Daily Gossip issued a ... training method will be published on their website at ... the article to inform readers about the information they will ... by reporters working at Daily Gossip, the article is a ... , Hiller has understood during the vast research he ...
(Date:6/19/2013)... NY (PRWEB) June 19, 2013 Researchers ... Sinai demonstrated several new studies at ENDO 2013, ... (ENDO) from June 15-18 in San Francisco.     , Mount ... well as the role of prostastic acid phosphatase (PAP) ... that can stimulate the thyroid gland; revealed the prevalence ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 HASCO ... today announced its intent to purchase privately held ... a leader in wheelchair accessible vehicle sales, service ... Auto Mobility Sales, Inc compliments and expands HASCO's ... wheelchair accessible mobility dealers . The acquisition is ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 CCA ... of Dr. John Baxter to Vice President, Health Services, ... as Director, Mental Health Services for CCA. He ... an honor and great privilege to lead CCA's dedicated ... unique opportunity to serve society and our partners as ...
(Date:6/19/2013)... Brain not working? Functional medicine pioneer ... seemingly minor brain problems as brain fog, memory loss, ... They indicate the brain may be degenerating—or aging—too quickly, ... stroke, and other neurological diseases. Why Isn’t My ... Press is now available online at Amazon ...
Breaking Medicine News(10 mins):Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 3Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 4Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 5Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 6Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 7Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:CCA Names Dr. John Baxter Vice President, Health Services 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3
... the Pew Research Center,s Forum on Religion & Public ... about the issue support President Barack Obama,s visit to ... most-observant Catholics and those who are less observant. These ... Obama,s job performance.Conducted from April 23-27, 2009, among 2,003 ...
... YORK, April 30 ProMetic Life Sciences Inc. ... Corporation of America ("SCOA") announces that it has ... ("SPI"), both wholly owned subsidiaries of Sumitomo Corporation ("Sumitomo") ... to PBI-1402 for the Japanese market.In the course of ...
... used to treat Type 2 diabetes may have unintended effects on ... in some patients and a greater risk of pancreatic cancer in ... , In a study published in the online edition of the ... Research Center at UCLA found that sitagliptin, sold in pill form ...
... April 30 Immucor, Inc. (Nasdaq: BLUD ... to the blood transfusion industry, today announced that access ... Merrill Lynch 2009 Health Care Conference in New York, ... The Company,s presentation is scheduled for Tuesday, May ...
... focus to neurovascular interventions developer.PALO ALTO, Calif., April 30 ... its directors elected Eric P. Milledge as Chairman of ... business acumen and leadership to Nfocus, as ... in the dynamic field of endovascular neurosurgery," noted President ...
... Association Minnesota-North Dakota in collaboration with the Hennepin County ... Project on May 12 at 6:00 p.m. at the ... by a question-and-answer panel of medical experts and caregivers. ... Alzheimer,s Project shows there is now genuine reason to ...
Cached Medicine News:Health News:New Poll on Obama, Catholics and the Notre Dame Commencement Finds Deep Divisions Among Catholics 2Health News:Sumitomo to Act As Advisor to ProMetic for Japanese Market 2Health News:Sumitomo to Act As Advisor to ProMetic for Japanese Market 3Health News:Sumitomo to Act As Advisor to ProMetic for Japanese Market 4Health News:Popular diabetes treatment could trigger pancreatitis, pancreatic cancer 2Health News:Popular diabetes treatment could trigger pancreatitis, pancreatic cancer 3Health News:Nfocus Neuromedical Elects Eric P. Milledge Chairman of Board 2Health News:The Alzheimer's Project HBO Documentary Puts Spotlight On Alzheimer's Disease; Premiere Screening at the Hennepin County Library in Downtown Minneapolis 2
(Date:6/19/2013)... , June 19, 2013 Pharmacyclics, Inc. (the ... The New England Journal of Medicine ( ... study evaluating the investigational oral Bruton,s tyrosine kinase (BTK) ... (CLL) or small lymphocytic lymphoma (SLL). Ibrutinib was shown ... CLL or SLL, even in patients who were at ...
(Date:6/19/2013)... June 19, 2013 The Physician-Patient Alliance for Health ... The need to urgently address this issue has ... Event Alert #50 , "Medical device alarm safety in hospitals." ... January 2008 and June 2012, there were 98 alarm related ... death (82%) , 13 resulted in permanent loss of ...
(Date:6/19/2013)... YORK , June 19, 2013   Voices ... to finding a cure for brain cancer, today announced ... a grant to support the clinical investigation of Toca ... recurrent high grade glioma brain cancer (Grade 3 or ... developing novel treatments for advanced cancer, with an initial ...
Breaking Medicine Technology:Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3
... , NEW ... market research report is available in its catalogue. , ... http://www.reportlinker.com/p0164740/US-Market-for-PACS-and-EMR.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , ... almost $1.3 billion, representing an increase of 6.7% over ...
... ... Reportlinker.com announces that a new market research report ... Nonwoven Disposables - A Worldwide Market Review ... , With increase in range of infectious ...
Cached Medicine Technology:Reportlinker Adds U.S. Market for PACS and EMR 2Reportlinker Adds U.S. Market for PACS and EMR 3Reportlinker Adds U.S. Market for PACS and EMR 4Reportlinker Adds U.S. Market for PACS and EMR 5Reportlinker Adds U.S. Market for PACS and EMR 6Reportlinker Adds U.S. Market for PACS and EMR 7Reportlinker Adds U.S. Market for PACS and EMR 8Reportlinker Adds U.S. Market for PACS and EMR 9Reportlinker Adds U.S. Market for PACS and EMR 10Reportlinker Adds U.S. Market for PACS and EMR 11Reportlinker Adds U.S. Market for PACS and EMR 12Reportlinker Adds U.S. Market for PACS and EMR 13Reportlinker Adds U.S. Market for PACS and EMR 14Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 2Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 3Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 4Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 5Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 6Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 7Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 8Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 9
The Foundation PS knee offers a femoral option and tibial insert which provides a specially designed cam action that engages at 60 degrees of flexion to induce a smooth stable femoral roll-back motio...
... Natural Knee design includes several ... CSTi porous coating option for ... a unique bone preserving posterior ... groove to maximize range of ...
... Total Knee System provides anatomical replacement of ... while preserving the stabilizing Anterior and Posterior ... motion of the knee. All the components ... sizes and are equally proportioned and contoured ...
Advance Posterior Stabilized Total Knee systems improves patellofemoral kinematics, reduces wear rate potential, increases resistance to posterior tibial dislocation, achieves at least 120o flexion i...
Medicine Products: